ARTICLE | Clinical News
Bristol-Myers preclinical data
June 18, 2007 7:00 AM UTC
Researchers published in Nature that BMS309403 reduced atherosclerotic lesions in mice by about 50% vs. controls. The compound also significantly increased insulin sensitivity and glucose metabolism v...